Inventor · disambiguated record
Paul Rothenberg
Also filed as: ROTHENBERG PAUL · ROTHENBERG PAUL L
3 granted patents·5 pending applications·56 citations·filing 1992–2020
71Inventor score
Top patents by PatentIndex Score
8 records- 0178US11207337B2Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disordersJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 28, 2021·1 cites·10 claims
- 0277US5260200AIsolated DNA encoding an insulin receptor substrateJOSLIN DIABETES CENTER INC·Filed 1992·Granted Nov 9, 1993·39 cites·7 claims
- 0359US2016022632A1Combination of canagliflozin and probenecid for the treament of hyperuricemiaJANSSEN PHARMACEUTICA NV·Filed 2014·Application pending·0 cites
- 0452US5621075AInsulin receptor substrateJOSLIN DIABETES CENTER INC·Filed 1993·Granted Apr 15, 1997·16 cites·4 claims
- 0552US2019142855A1Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disordersJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 0648US2022315633A1Gdf15 analogs and methods for use in decreasing body weight and/or reducing food intakeJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 0746US2017368025A1Combination of canagliflozin and probenecid for the treament of hyperuricemiaJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 0845US2017071970A1Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disordersJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Rothenberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →